Informed consent obtained prior to any screening procedure 
Caucasian male or female patient 
At least 18 years of age 
Weight at least 45 kg 
Patient with moderate or severe chronic atopic dermatitis 
Good general health ascertained by medical history, physical examination and laboratory determinations, showing no signs of clinically significant findings, except chronic atopic dermatitis 
Negative pregnancy test (premenopausal female patient) at screening and use of adequate contraceptive measures (both male and female patients) throughout the study and 30 days after the last cis-UCA dose 

NCT01320579_inc_T2
Person
Caucasian
NCT01320579_inc_T3
Person
male
NCT01320579_inc_T4
Person
female
NCT01320579_inc_T5
Value
At least 18 years
NCT01320579_inc_T6
Person
age
NCT01320579_inc_T7
Measurement
Weight
NCT01320579_inc_T8
Value
at least 45 kg
NCT01320579_inc_T9
Condition
chronic atopic dermatitis
NCT01320579_inc_T10
Qualifier
severe
NCT01320579_inc_T11
Qualifier
moderate
NCT01320579_inc_T12
Scope
moderate or severe
NCT01320579_inc_T13
Condition
Good general health
NCT01320579_inc_T14
Observation
medical history
NCT01320579_inc_T15
Procedure
physical examination
NCT01320579_inc_T16
Procedure
laboratory determinations
NCT01320579_inc_T17
Negation
no
NCT01320579_inc_T18
Observation
signs of clinically significant findings
NCT01320579_inc_T19
Qualifier
clinically significant
NCT01320579_inc_T21
Condition
chronic atopic dermatitis
NCT01320579_inc_T22
Negation
except
NCT01320579_inc_T23
Qualifier
ascertained by medical history, physical examination and laboratory determinations
NCT01320579_inc_T24
Measurement
pregnancy test
NCT01320579_inc_T25
Value
Negative
NCT01320579_inc_T26
Condition
premenopausal
NCT01320579_inc_T27
Person
female
NCT01320579_inc_T28
Scope
premenopausal female